{"web_url": "http://www.nytimes.com/2013/12/04/business/rare-cancer-treatments-cleared-by-fda-but-not-subject-to-scrutiny.html", "snippet": "The F.D.A. allows the sale of some devices to treat small groups of patients without requiring proof that the devices work, or any rigorous study of the medical results.", "lead_paragraph": "The F.D.A. allows the sale of some devices to treat small groups of patients without requiring proof that the devices work, or any rigorous study of the medical results.", "abstract": "Little-known Food and Drug Administration regulation, known as the humanitarian device exemption, allows sale of some devices to treat small groups of patients without requiring proof that the devices work, or any rigorous study of the medical results; critics say ineffective products approved under exemption can be sold for years while potentially lifesaving ones may never prove their worth.", "print_page": "1", "blog": [], "source": "The New York Times", "multimedia": [{"width": 190, "url": "images/2013/12/04/business/JP-CANCER/JP-CANCER-thumbWide-v2.jpg", "height": 126, "subtype": "wide", "legacy": {"wide": "images/2013/12/04/business/JP-CANCER/JP-CANCER-thumbWide-v2.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"width": 600, "url": "images/2013/12/04/business/CANCER/CANCER-articleLarge.jpg", "height": 722, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlarge": "images/2013/12/04/business/CANCER/CANCER-articleLarge.jpg", "xlargeheight": "722"}, "type": "image"}, {"width": 75, "url": "images/2013/12/04/business/CANCER/CANCER-thumbStandard-v2.jpg", "height": 75, "subtype": "thumbnail", "legacy": {"thumbnailheight": "75", "thumbnail": "images/2013/12/04/business/CANCER/CANCER-thumbStandard-v2.jpg", "thumbnailwidth": "75"}, "type": "image"}], "headline": {"main": "Rare Cancer Treatments, Cleared by F.D.A. but Not Subject to Scrutiny", "print_headline": "Rare Treatments, Cleared by F.D.A. but Not Subject to Scrutiny"}, "keywords": [{"rank": "5", "is_major": "N", "value": "BSD Medical Corporation", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Research", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Regulation and Deregulation of Industry", "name": "subject"}, {"rank": "1", "is_major": "Y", "value": "Medical Devices", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Cancer", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Food and Drug Administration", "name": "organizations"}], "pub_date": "2013-12-04T00:00:00Z", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "firstname": "Barry", "rank": 1, "lastname": "MEIER"}], "original": "By BARRY MEIER"}, "type_of_material": "News", "_id": "529e896038f0d866f626e152", "word_count": "1372", "slideshow_credits": null}